| Stage | AEBI | % of rev | CAT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $496M | 100.00% | $20.5B | 100.00% | CAT ×41.38 |
| Gross profit | $97M | 19.60% | $7.8B | 37.78% | CAT +18.2pp |
| Operating income | $27M | 5.45% | $4.3B | 20.91% | CAT +15.5pp |
| Pre-tax income | $15M | 3.09% | $4.6B | 22.19% | CAT +19.1pp |
| Net income | $10M | 2.11% | $3.6B | 17.49% | CAT +15.4pp |
| Stage | AEBI | CAT | Gap · A − B |
|---|---|---|---|
| Revenue | $496M100.00% | $20.5B100.00% | CAT ×41.38 |
| Gross profit | 19.60%$97M | 37.78%$7.8B | CAT +18.2pp |
| Operating income | 5.45%$27M | 20.91%$4.3B | CAT +15.5pp |
| Pre-tax income | 3.09%$15M | 22.19%$4.6B | CAT +19.1pp |
| Net income |
| 2.11%$10M |
| 17.49%$3.6B |
| CAT +15.4pp |
No shared counterparties.